학술논문
Management and outcomes of non–small cell lung cancer patients with rapid progression under second-or-more-line immune checkpoint inhibitors: ERORECI study (GFPC 2016-04)
Document Type
Article
Author
Source
In: Cancer Medicine . (Cancer Medicine, 1 January 2020, 9(2):432-439)
Subject
Language
English
ISSN
20457634